{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:19:25Z","timestamp":1785302365023,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["CoV19-0304"],"award-info":[{"award-number":["CoV19-0304"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-026-00928-9","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:36:09Z","timestamp":1772184969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic variations in AAK1 and ADAM17 associated with circulatory cytokines changes influence COVID-19 susceptibility and severity"],"prefix":"10.1186","volume":"20","author":[{"given":"Amal","family":"Bouzid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"Elemam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habiba","family":"Alsafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thenmozhi","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Eldoahji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Halabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman M.","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Taneera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzam A.","family":"Maghazachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qutayba","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Saber-Ayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1","key":"928_CR1","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1038\/s41467-020-19057-5","volume":"11","author":"J Fajnzylber","year":"2020","unstructured":"Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493.","journal-title":"Nat Commun"},{"issue":"3","key":"928_CR2","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1002\/iid3.580","volume":"10","author":"O Dadras","year":"2022","unstructured":"Dadras O, Afsahi AM, Pashaei Z, Mojdeganlou H, Karimi A, Habibi P, et al. The relationship between COVID-19 viral load and disease severity: A systematic review. Immun Inflamm Dis. 2022;10(3):e580.","journal-title":"Immun Inflamm Dis"},{"key":"928_CR3","doi-asserted-by":"crossref","unstructured":"Le K, Kannappan S, Kim T, Lee JH, Lee HR, Kim KK. Structural understanding of SARS-CoV-2 virus entry to host cells. Front Mol Biosci. 2023. https:\/\/www.frontiersin.org\/journals\/molecular-biosciences\/articles\/10.3389\/fmolb.2023.1288686\/full. Accessed 30 May 2025.","DOI":"10.3389\/fmolb.2023.1288686"},{"issue":"1","key":"928_CR4","doi-asserted-by":"publisher","first-page":"20728","DOI":"10.1038\/s41598-024-71476-2","volume":"14","author":"P Delgado-Wicke","year":"2024","unstructured":"Delgado-Wicke P, Fern\u00e1ndez de C\u00f3rdoba-O\u00f1ate S, Roy-Vallejo E, Alegr\u00eda-Carrasco E, Rodr\u00edguez-Serrano DA, Lamana A, et al. Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables. Sci Rep. 2024;14(1):20728.","journal-title":"Sci Rep"},{"key":"928_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1146\/annurev-biochem-062917-012644","volume":"87","author":"M Mettlen","year":"2018","unstructured":"Mettlen M, Chen PH, Srinivasan S, Danuser G, Schmid SL. Regulation of Clathrin-Mediated endocytosis. Annu Rev Biochem. 2018;87:871\u201396.","journal-title":"Annu Rev Biochem"},{"key":"928_CR6","doi-asserted-by":"publisher","first-page":"105367","DOI":"10.1016\/j.antiviral.2022.105367","volume":"204","author":"M Karim","year":"2022","unstructured":"Karim M, Saul S, Ghita L, Sahoo MK, Ye C, Bhalla N, et al. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies. Antiviral Res. 2022;204:105367.","journal-title":"Antiviral Res"},{"issue":"11","key":"928_CR7","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.3390\/ijms25115911","volume":"25","author":"J Sun","year":"2024","unstructured":"Sun J, Edsfeldt A, Svensson J, Ruge T, Goncalves I, Sw\u00e4rd P. ADAM-17 activity and its relation to ACE2: implications for severe COVID-19. Int J Mol Sci. 2024;25(11):5911.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"928_CR8","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S2213-2600(20)30354-4","volume":"8","author":"E Pujadas","year":"2020","unstructured":"Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wajnberg A, et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8(9):e70.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"928_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"928_CR10","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/cells13242092","volume":"13","author":"M Sisto","year":"2024","unstructured":"Sisto M, Lisi S. Updates on inflammatory molecular pathways mediated by ADAM17 in autoimmunity. Cells. 2024;13(24):2092.","journal-title":"Cells"},{"issue":"8","key":"928_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.it.2011.05.005","volume":"32","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Garbers C, Rose-John S. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol. 2011;32(8):380\u20137.","journal-title":"Trends Immunol"},{"key":"928_CR12","doi-asserted-by":"crossref","unstructured":"Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q et al. CD209L\/L-SIGN and CD209\/DC-SIGN act as receptors for SARS-CoV-2. BioRxiv Prepr Serv Biol. 2021;2020.06.22.165803.","DOI":"10.1101\/2020.06.22.165803"},{"issue":"5","key":"928_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/ng1550","volume":"37","author":"A Sakuntabhai","year":"2005","unstructured":"Sakuntabhai A, Turbpaiboon C, Casad\u00e9mont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet. 2005;37(5):507\u201313.","journal-title":"Nat Genet"},{"issue":"1","key":"928_CR14","doi-asserted-by":"publisher","first-page":"e934","DOI":"10.1371\/journal.pntd.0000934","volume":"5","author":"L Wang","year":"2011","unstructured":"Wang L, Chen RF, Liu JW, Lee IK, Lee CP, Kuo HC, et al. DC-SIGN (CD209) Promoter\u2009\u2013\u2009336 A\/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis. 2011;5(1):e934.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"928_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jiph.2024.02.001","volume":"17","author":"M Kanan","year":"2024","unstructured":"Kanan M, Naffaa M, Alanazi A, Nasser F, Alsaiari AA, Almehmadi M, et al. Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis. J Infect Public Health. 2024;17(4):579\u201387.","journal-title":"J Infect Public Health"},{"key":"928_CR16","doi-asserted-by":"crossref","unstructured":"de Oliveira LF, de Lima CPS, Azevedo R do, de SS, Mendon\u00e7a DSF, Rodrigues SG, Carvalho VL et al. Polymorphism of DC-SIGN (CD209) promoter in association with clinical symptoms of dengue fever. Viral Immunol. 2014;27(5):245\u20139.","DOI":"10.1089\/vim.2013.0119"},{"issue":"8","key":"928_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.5551\/jat.22400","volume":"21","author":"Y Li","year":"2014","unstructured":"Li Y, Cui LL, Li QQ, Ma GD, Cai YJ, Chen YY, et al. Association between ADAM17 promoter polymorphisms and ischemic stroke in a Chinese population. J Atheroscler Thromb. 2014;21(8):878\u201393.","journal-title":"J Atheroscler Thromb"},{"key":"928_CR18","doi-asserted-by":"crossref","unstructured":"Yuan YH, Mao,Nian-Dong et al. Duan, Ji-Long, Zhang, Hang, Garrido, Carmen, Lirussi, Fr\u00e9d\u00e9ric,. Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents. J Enzyme Inhib Med Chem. 2023;38(1):2279906.","DOI":"10.1080\/14756366.2023.2279906"},{"issue":"10223","key":"928_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"7821","key":"928_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463\u20139.","journal-title":"Nature"},{"issue":"10","key":"928_CR21","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636\u201343.","journal-title":"Nat Med"},{"issue":"6","key":"928_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41577-020-0328-z","volume":"20","author":"O Pacha","year":"2020","unstructured":"Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17? Nat Rev Immunol. 2020;20(6):345\u20136.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"928_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M\u00f8ller R, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036\u2013e10459.","journal-title":"Cell"},{"issue":"6508","key":"928_CR24","doi-asserted-by":"publisher","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):eabc8511.","journal-title":"Science"},{"key":"928_CR25","doi-asserted-by":"publisher","first-page":"109177","DOI":"10.1016\/j.clim.2022.109177","volume":"245","author":"M Alahdal","year":"2022","unstructured":"Alahdal M, Elkord E. Exhaustion and over-activation of immune cells in COVID-19: challenges and therapeutic opportunities. Clin Immunol. 2022;245:109177.","journal-title":"Clin Immunol"},{"issue":"23","key":"928_CR26","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255\u201373.","journal-title":"N Engl J Med"},{"issue":"6504","key":"928_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718\u201324.","journal-title":"Science"},{"key":"928_CR28","doi-asserted-by":"crossref","unstructured":"Elemam NM, Bouzid A, Alsafar H, Ahmed SB, Hafezi S, Venkatachalam T et al. Association of specific ACE2 and TMPRSS2 variants with circulatory cytokines of COVID-19 Emirati patients. Front Immunol. 2024 https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2024.1348229\/full. Accessed 26 Oct 2024.","DOI":"10.3389\/fimmu.2024.1348229"},{"key":"928_CR29","unstructured":"COVID-19 Therapeutic Trial Synopsis. https:\/\/www.who.int\/publications\/i\/item\/covid-19-therapeutic-trial-synopsis. Accessed 21 Jan 2026."},{"key":"928_CR30","doi-asserted-by":"publisher","unstructured":"Gouda HR, Talaat IM, Bouzid A, El-Assi H, Nabil A, Venkatachalam T et al. Genetic analysis of CFH and MCP in Egyptian patients with immune-complex proliferative glomerulonephritis. Front Immunol. 2022 https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2022.960068. Accessed 25 Sep 2022.","DOI":"10.3389\/fimmu.2022.960068"},{"issue":"1","key":"928_CR31","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1038\/s41598-022-26072-7","volume":"12","author":"N Jalaleddine","year":"2022","unstructured":"Jalaleddine N, Bouzid A, Hachim M, Sharif-Askari NS, Mahboub B, Senok A, et al. ACE2 polymorphisms impact COVID-19 severity in obese patients. Sci Rep. 2022;12(1):21491.","journal-title":"Sci Rep"},{"issue":"13","key":"928_CR32","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812\u20134.","journal-title":"Nucleic Acids Res"},{"key":"928_CR33","doi-asserted-by":"crossref","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;Chap. 7:Unit7.20.","DOI":"10.1002\/0471142905.hg0720s76"},{"issue":"4","key":"928_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877\u201385.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"928_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310\u20135.","journal-title":"Nat Genet"},{"key":"928_CR36","doi-asserted-by":"publisher","unstructured":"Dong S, Zhao N, Spragins E, Kagda MS, Li M, Assis P et al. Annotating and prioritizing human non-coding variants with RegulomeDB. bioRxiv; 2022. https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/2022.10.18.512627v1. Accessed 15 Jan 2025.","DOI":"10.1101\/2022.10.18.512627v1"},{"key":"928_CR37","doi-asserted-by":"crossref","unstructured":"Gulko B, Gronau I, Hubisz MJ, Siepel A. Probabilities of Fitness Consequences for Point Mutations Across the Human Genome. bioRxiv; 2014 https:\/\/www.biorxiv.org\/content\/10.1101\/006825v1. Accessed 16 Jan 2025.","DOI":"10.1101\/006825"},{"issue":"2","key":"928_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ng.3477","volume":"48","author":"I Ionita-Laza","year":"2016","unstructured":"Ionita-Laza I, McCallum K, Xu B, Buxbaum JD. A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat Genet. 2016;48(2):214\u201320.","journal-title":"Nat Genet"},{"issue":"1","key":"928_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/humu.22225","volume":"34","author":"HA Shihab","year":"2013","unstructured":"Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GLA, Edwards KJ, et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat. 2013;34(1):57\u201365.","journal-title":"Hum Mutat"},{"issue":"2","key":"928_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/EDE.0000000000000224","volume":"26","author":"S Schwartz","year":"2015","unstructured":"Schwartz S, Campbell UB, Gatto NM, Gordon K. Toward a clarification of the taxonomy of bias in epidemiology textbooks. Epidemiology. 2015;26(2):216\u201322.","journal-title":"Epidemiology"},{"key":"928_CR41","doi-asserted-by":"publisher","first-page":"108385","DOI":"10.1016\/j.intimp.2021.108385","volume":"102","author":"J He","year":"2022","unstructured":"He J, Zhao T, Liu L, Liao S, Yang S, Lu F, et al. The \u2013\u2009172 A-to-G variation in ADAM17 gene promoter region affects EGR1\/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria. Int Immunopharmacol. 2022;102:108385.","journal-title":"Int Immunopharmacol"},{"key":"928_CR42","doi-asserted-by":"crossref","unstructured":"Elemam NM, Hammoudeh S, Salameh L, Mahboub B, Alsafar H, Talaat IM et al. Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling. Front Immunol. 2022 https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2022.865845\/full. Accessed 3 Sep 2025.","DOI":"10.3389\/fimmu.2022.865845"},{"issue":"6","key":"928_CR43","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s12265-022-10275-4","volume":"15","author":"BY Tang","year":"2022","unstructured":"Tang BY, Ge J, Wu Y, Wen J, Tang XH. The role of ADAM17 in Inflammation-Related atherosclerosis. J Cardiovasc Transl Res. 2022;15(6):1283\u201396.","journal-title":"J Cardiovasc Transl Res"},{"key":"928_CR44","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3389\/fphar.2020.01154","volume":"11","author":"TM de Queiroz","year":"2020","unstructured":"de Queiroz TM, Lakkappa N, Lazartigues E. ADAM17-Mediated shedding of inflammatory cytokines in hypertension. Front Pharmacol. 2020;11:1154.","journal-title":"Front Pharmacol"},{"issue":"1","key":"928_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-018-0183-x","volume":"8","author":"JX Pan","year":"2018","unstructured":"Pan JX, Xia JJ, Deng FL, Liang WW, Wu J, Yin BM, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry. 2018;8(1):1\u201310.","journal-title":"Transl Psychiatry"},{"issue":"10","key":"928_CR46","doi-asserted-by":"publisher","first-page":"e202201545","DOI":"10.26508\/lsa.202201545","volume":"5","author":"G Villapalos-Garc\u00eda","year":"2022","unstructured":"Villapalos-Garc\u00eda G, Zubiaur P, Rivas-Dur\u00e1n R, Campos-Norte P, Ar\u00e9valo-Rom\u00e1n C, Fern\u00e1ndez-Rico M, et al. Correction: Transmembrane protease Serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity. Life Sci Alliance. 2022;5(10):e202201545.","journal-title":"Life Sci Alliance"},{"issue":"11","key":"928_CR47","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.tig.2020.08.003","volume":"36","author":"P Brest","year":"2020","unstructured":"Brest P, Refae S, Mograbi B, Hofman P, Milano G. Host polymorphisms May impact SARS-CoV-2 infectivity. Trends Genet. 2020;36(11):813\u20135.","journal-title":"Trends Genet"},{"issue":"4","key":"928_CR48","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1159\/000447830","volume":"39","author":"Y Shao","year":"2016","unstructured":"Shao Y, He J, Chen F, Cai Y, Zhao J, Lin Y, et al. Association study between promoter polymorphisms of ADAM17 and progression of sepsis. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2016;39(4):1247\u201361.","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"928_CR49","doi-asserted-by":"publisher","first-page":"1392782","DOI":"10.3389\/fmicb.2024.1392782","volume":"15","author":"JA Chore\u00f1o-Parra","year":"2024","unstructured":"Chore\u00f1o-Parra JA, Ramon-Luing LA, Castillejos M, Ortega-Mart\u00ednez E, Tapia-Garc\u00eda AR, Mat\u00edas-Mart\u00ednez MB, et al. The rs11684747 and rs55790676 SNPs of ADAM17 influence tuberculosis susceptibility and plasma levels of TNF, TNFR1, and TNFR2. Front Microbiol. 2024;15:1392782.","journal-title":"Front Microbiol"},{"key":"928_CR50","first-page":"81","volume":"13","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Trinh NT, Choi Y, Kim W, Min KH, Kang SO, et al. ADAM17 genetic variants and the response of TNF-\u03b1 inhibitor in rheumatoid arthritis patients. Pharmacogenomics Pers Med. 2020;13:81\u20138.","journal-title":"Pharmacogenomics Pers Med"},{"issue":"5","key":"928_CR51","doi-asserted-by":"publisher","first-page":"e23751","DOI":"10.1002\/jcla.23751","volume":"35","author":"HC Chan","year":"2021","unstructured":"Chan HC, Wang SC, Lin CH, Lin YZ, Li RN, Yen JH. A novel CD209 polymorphism is associated with rheumatoid arthritis patients in Taiwan. J Clin Lab Anal. 2021;35(5):e23751.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"928_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41232-022-00253-3","volume":"43","author":"Y Tanaka","year":"2023","unstructured":"Tanaka Y. A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia. Inflamm Regen. 2023;43(1):3.","journal-title":"Inflamm Regen"},{"issue":"5","key":"928_CR53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000509483","volume":"10","author":"G Iannaccone","year":"2020","unstructured":"Iannaccone G, Scacciavillani R, Del Buono MG, Camilli M, Ronco C, Lavie CJ, et al. Weathering the cytokine storm in COVID-19: therapeutic implications. Cardiorenal Med. 2020;10(5):277\u201387.","journal-title":"Cardiorenal Med"},{"issue":"12","key":"928_CR54","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1172\/JCI141772","volume":"130","author":"V Bronte","year":"2020","unstructured":"Bronte V, Ugel S, Tinazzi E, Vella A, De Sanctis F, Can\u00e8 S, et al. Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest. 2020;130(12):6409\u201316.","journal-title":"J Clin Invest"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00928-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00928-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00928-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:03:59Z","timestamp":1775225039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00928-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["928"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00928-9","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Dubai Scientific Research Ethics Committee, Dubai, UAE. The study was conducted in accordance with the Declaration of Helsinki and the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. COVID-19 patients were recruited under the ethical approval number: DSREC-04\/2020 09 on April 26, 2020, and the healthy control cases were collected under the ethical approval number: MO-HAP\/DXB\/SUBC\/No.14\/2017. All data of patients used in this study were anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}